← Leaderboards
Elad Ziv
University Of California, San Francisco
$19,093,596
Attributed
$26,900,700
Total exposure
18
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.4M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$27,705,061 · 19
By mechanism
R01$20,923,453 · 9
K24$1,830,103 · 1
P20$1,608,722 · 3
T32$1,396,360 · 1
R21$773,237 · 2
U54$453,954 · 1
Top collaborators
- Susan L. Neuhausen6 shared
- Iona C Cheng4 shared
- Luisa N Borrell3 shared
- Max A Seibold3 shared
- Noah A Zaitlen3 shared
- Celine M Vachon2 shared
- Nadav Ahituv1 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Diane V Havlir$125,216,731
- Daniel B Vigneron$43,424,992
- Bruce L Miller$34,542,477
- Nola M. Hylton$19,153,972
- William A Weiss$31,543,847
Others in their field
Top investigators on “Genetic”
- Richard A Gibbs · Baylor College Of Medicine$577,061,667
- Eric S Lander · Whitehead Institute For Biomedical Res$560,806,052
- David R. Weir · University Of Michigan At Ann Arbor$322,225,557
- Richard K. Wilson · Washington University$316,685,275
- Lawrence Corey · Fred Hutchinson Cancer Center$312,182,347
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$302,429,647
Research focus
GeneticGenome Wide Association StudyVariantData SetGenesWomanAffectBaseMalignant Breast NeoplasmGenetic VariantHigh RiskGenotypeLatinaPredispositionPathway InteractionsGene ExpressionAllelesResponseTumorSamplingTraitBiologicalComplexCancer Risk
Grant awards (56)
Germline variation in homologous recombination repair genes in Hispanic/Latina women to predict breast cancer risk and response to treatment$4,307,388
R01 · FY2025 · MD · contact PI
Evaluating the clinical implications for ACKR1/DARC associated neutropenia$619,254
R01 · FY2025 · HL · contact PI
Project 3: Understanding genomic and external drivers of response-predictive inflammatory states underlying differences in clinical outcomes in patients with breast cancer$453,954
U54 · FY2025 · CA · contact PI
Race and ancestry as predictors of the tumor immune microenvironment and response to immunotherapy$435,007
P20 · FY2025 · CA · contact PI
Admin Core$217,504
P20 · FY2025 · CA · contact PI
Project-Race and ancestry as predictors of the tumor immune microenvironment and response to immunotherapy$217,503
P20 · FY2025 · CA · contact PI
Core C : Population Genomic Risk Assessment$125,152
P01 · FY2025 · CA · contact PI
Epigenomics of asthma risk factors and clinical subtypes in minority children$700,325
R01 · FY2024 · HL · contact PI
Evaluating the clinical implications for ACKR1/DARC associated neutropenia$686,997
R01 · FY2024 · HL · contact PI
Race and ancestry as predictors of the tumor immune microenvironment and response to immunotherapy$369,354
P20 · FY2024 · CA · contact PI
Training in the Molecular & Genetic Epidemiology of Cancer$342,945
T32 · FY2024 · CA
Project-Race and ancestry as predictors of the tumor immune microenvironment and response to immunotherapy$313,039
P20 · FY2024 · CA · contact PI
Core C : Population Genomic Risk Assessment$145,954
P01 · FY2024 · CA · contact PI
Admin Core$56,315
P20 · FY2024 · CA · contact PI
Epigenomics of asthma risk factors and clinical subtypes in minority children$716,814
R01 · FY2023 · HL · contact PI
Evaluating the clinical implications for ACKR1/DARC associated neutropenia$692,942
R01 · FY2023 · HL · contact PI
Training in the Molecular & Genetic Epidemiology of Cancer$331,879
T32 · FY2023 · CA
(8) Genetics of Immune Related Adverse Events and Response to Immunotherapy$309,948
R01 · FY2023 · CA · contact PI
The Airway Functional Genomics of Bronchodilator Drug Response in Minority Children with Asthma$790,190
R01 · FY2022 · HL · contact PI
Epigenomics of asthma risk factors and clinical subtypes in minority children$719,085
R01 · FY2022 · HL · contact PI
(8) Genetics of Immune Related Adverse Events and Response to Immunotherapy$583,603
R01 · FY2022 · CA · contact PI
Training in the Molecular & Genetic Epidemiology of Cancer$352,270
T32 · FY2022 · CA
Transcriptomic and Pharmacogenetic Asthma Endotypes in Minority Children$729,775
R01 · FY2021 · HL
(8) Genetics of Immune Related Adverse Events and Response to Immunotherapy$671,059
R01 · FY2021 · CA · contact PI
Training in the Molecular & Genetic Epidemiology of Cancer$369,266
T32 · FY2021 · CA
Genetics of mammographic density and breast cancer risk in Latinas$187,919
K24 · FY2021 · CA · contact PI
Genes, air pollution, and asthma severity in minority children$706,771
R01 · FY2020 · MD · contact PI
(8) Genetics of Immune Related Adverse Events and Response to Immunotherapy$389,055
R01 · FY2020 · CA · contact PI
Genetics of mammographic density and breast cancer risk in Latinas$187,919
K24 · FY2020 · CA · contact PI
(8) Genetics of Immune Related Adverse Events and Response to Immunotherapy$634,715
R01 · FY2019 · CA · contact PI
Genetics of mammographic density and breast cancer risk in Latinas$187,919
K24 · FY2019 · CA · contact PI
Germline and Tumor Genomic Analyses of Breast Cancer in Latinas$789,245
R01 · FY2018 · CA
(8) Genetics of Immune Related Adverse Events and Response to Immunotherapy$699,062
R01 · FY2018 · CA · contact PI
Genetics of mammographic density and breast cancer risk in Latinas$187,919
K24 · FY2018 · CA · contact PI
Germline and Tumor Genomic Analyses of Breast Cancer in Latinas$802,610
R01 · FY2017 · CA
Genetics of mammographic density and breast cancer risk in Latinas$187,919
K24 · FY2017 · CA · contact PI
Germline and Tumor Genomic Analyses of Breast Cancer in Latinas$817,565
R01 · FY2016 · CA
Genetic and Epidemiological Approaches to Breast Density and Breast Cancer Risk$178,239
K24 · FY2016 · CA · contact PI
Influence of germ line genetic variation on myeloma progression and survival$176,240
R21 · FY2016 · CA · contact PI
Germline and Tumor Genomic Analyses of Breast Cancer in Latinas$846,252
R01 · FY2015 · CA
Influence of germ line genetic variation on myeloma progression and survival$230,502
R21 · FY2015 · CA · contact PI
Genetic and Epidemiological Approaches to Breast Density and Breast Cancer Risk$178,502
K24 · FY2015 · CA · contact PI
Germline and Tumor Genomic Analyses of Breast Cancer in Latinas$909,614
R01 · FY2014 · CA
Genetic and Epidemiological Approaches to Breast Density and Breast Cancer Risk$178,000
K24 · FY2014 · CA · contact PI
Genetics of Mammographic Density in Ashkenazi Jews$166,495
R21 · FY2014 · CA · contact PI
Genetics of Mammographic Density in Ashkenazi Jews$200,000
R21 · FY2013 · CA · contact PI
Genetic and Epidemiological Approaches to Breast Density and Breast Cancer Risk$178,592
K24 · FY2013 · CA · contact PI
Genetic and Epidemiological Approaches to Breast Density and Breast Cancer Risk$177,175
K24 · FY2012 · CA · contact PI
Admixture Mapping for Breast Cancer in Latinas$411,079
R01 · FY2011 · CA · contact PI
Admixture Mapping for Breast Cancer in Latinas$559,501
R01 · FY2010 · CA · contact PI
Admixture Mapping for Breast Cancer in Latinas$588,827
R01 · FY2009 · CA · contact PI
Admixture Mapping for Breast Cancer in Latinas$615,317
R01 · FY2008 · CA · contact PI
Admixture Mapping for Breast Cancer in Latinas$626,460
R01 · FY2007 · CA · contact PI
Breast Cancer, Breast Density & Admixture Among Latinas$149,067
K22 · FY2006 · CA · contact PI
Breast Cancer, Breast Density &Admixture Among Latinas$149,509
K22 · FY2005 · CA
Breast Cancer, Breast Density &Admixture Among Latinas$149,550
K22 · FY2004 · CA